Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07683949 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine

Study acronym: LENCAP-CRC
StatusEnrolling by Invitation
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy
Trial Details
NCT Number NCT07683949
Lead Sponsor Seoul National University Bundang Hospital
Collaborators: Seoul National University Hospital
Conditions
(from sponsor)		 Advanced Colorectal Cancer (Part 1)
Enrollment 93 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov